Single Arm, Prospective, Open Label, Multicenter Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems in the Visualization of Lymphatic Vessels and Lymph Nodes During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Subjects With Breast Cancer
Phase of Trial: Phase III
Latest Information Update: 14 Feb 2019
At a glance
- Drugs IC 2000 (Primary)
- Indications Breast cancer; Carcinoma
- Focus Diagnostic use; Registrational
- Acronyms FILM-B
- Sponsors Novadaq Technologies
- 05 Feb 2019 Status changed from not yet recruiting to recruiting.
- 18 Jan 2019 Planned number of patients changed from 110 to 200.
- 18 Jan 2019 Planned End Date changed from 1 Oct 2019 to 1 Dec 2019.